Welcome to StemCellPatents.com! A Free Comprehensive Index of The Stem Cell Patents IP Minefield. Learn more.

FEATURED NEWS

Apoptotic Cells Secrete Angiogenic Factors

It is a medical mystery why approaches such as extracorporeal ozone therapy or even photopheresis seem to have therapeutic effects in certain situations.  One possibility is that stressing of cells outside of the body causes formation of apoptotic bodies, with the apoptotic bodies having a therapeutic effect.

The possibility of apoptotic bodies... [Read more]

LATEST STEM CELL & STEM CELL PATENT NEWS

Hair Stem Cells for Injured Nerves

June 10th

Sagamihara, Japan -

Hair follicle stem cells have previously been demonstrated to possess various characteristics of other stem cells, including migration to SDF-1, thus potentially allowing intravenous injection.  Also this stem cell population has been proposed, along with adipose stem cells, to have immune... [Read more]

Pulmonary Fibrosis Treated by Mesenchymal Stem Cells

June 8th

Melbourne, Australia -

Systemic administration of stem cells is usually associated with preferential localization into the lung and liver.  Lung conditions such as acute respiratory distress syndrome have no cure with exception of transplantation, which is limited to a small number of patients.  The rationale of using mesenchymal stem cells for pulmonary diseases comes from... [Read more]

Free bone allograft prevents acute immune reaction

May 26th

London, Canada -

Antibody-mediated acute vascular rejection (AVR) is a major problem in organ transplantation.  The C3H to BALB/c heterotopic (second heart) cardiac transplant model resembles the human condition of AVR.  When recipients are given a course of the conventionally used immune suppressant agent cyclosporin A, grafts survive 15 days.  This is approximately 8 days... [Read more]

G-CSF Makes You Smarter

May 16th

Münster, Germany -

G-CSF is widely used as a stem cell mobilizer, inducing complement-dependent exit of CD34 and mesenchymal stem cells from the bone marrow.  It has been postulated that G-CSF has not just hematopoietic but also neurogenic activity.  For example, a study reported that G-CSF administration... [Read more]

Mouse Liver Failure Treated by Human Cord Blood Stem Cells

May 15th

Sacramento, CA -

It is known that administration of autologous bone marrow cells into patients with liver failure induces clinical improvement, at least in pilot trials of cirrhotic patients.  Mechanistically this may work through the process of transdifferentiation, that is, bone marrow directly differentiating to... [Read more]

1 Comment



MORE NEWS
Go to News Section

Stromal antigen-presenting cells and use thereof

Mesenchymal stem cells are known to possess a variety of immune modulatory activities such as suppression of allogeneic responses, as well as induction of T regulatory cells.  Mechanisms include expression of IDO and [Read more]

Sign-up for the Free StemCellPatents.com Newsletter!

RECENTLY ADDED STEM CELL PATENTS

SPONSORED LINKS


Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2009 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03